Edesa Biotech, Inc. Common Shares
Symbol: EDSA (NASDAQ)
2.41
▼ (-1.36%) -0.033
Company Description:
Edesa Biotech Inc is a biotechnology company focused on inflammatory and immune-related diseases. It is involved in exploring novel ways to treat these diseases, including alternatives to topical steroids, which can have side effects. The company's product candidate, EB06, is an anti-CXCL10 monoclonal antibody candidate and is being developed as a therapy for vitiligo, a common autoimmune disorder that causes the skin to lose its color in patches. The other drug candidates in its product pipeline include EB05, EB07, and EB01 which are in their different phases of development.
Key Stats
- Today's Open: $2.455
- Today's High: $2.479
- Today's Low: $2.406
- Today's Volume: 4.53K
- Yesterday Close: $2.4433
- Yesterday High: $2.48
- Yesterday Low: $2.43
- Yesterday Volume: 7.54K
- Last Min Volume: 3
- Last Min High: $2.41
- Last Min Low: $2.41
- Last Min VWAP: $2.41
Company Profile
- Name: Edesa Biotech, Inc. Common Shares
- Website: https://www.edesabiotech.com
- Listed Date: 2010-06-21
- Location: MARKHAM, A6
- Market Status: Active
- CIK Number: 0001540159
- SIC Code: 2834
- SIC description: PHARMACEUTICAL PREPARATIONS
- Market Cap: $17.20M
- Round Lot: 100
- Outstanding Shares: 7.04M
- Asset Type: CS
RECENT FILINGS FOR EDSA
| Filing Date | Filing Type | Format |
|---|---|---|
| 2025-09-09 | EFFECT | View |
| 2025-09-09 | 8-K | View |
| 2025-09-09 | 424B5 | View |
| 2025-08-08 | 10-Q | View |
| 2025-08-08 | 8-K | View |
| 2025-08-04 | 4 | View |
| 2025-07-25 | S-3 | View |
| 2025-07-02 | 4 | View |
| 2025-06-02 | 4 | View |
| 2025-06-02 | 4 | View |
| 2025-06-02 | 4 | View |
| 2025-06-02 | 4 | View |
| 2025-06-02 | 4 | View |
| 2025-06-02 | 4 | View |
| 2025-06-02 | 4 | View |
| 2025-06-02 | 4 | View |
| 2025-06-02 | 4 | View |
| 2025-05-28 | S-8 | View |
| 2025-05-28 | 8-K | View |
| 2025-05-15 | SCHEDULE 13G | View |
Latest News on EDSA